🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joel D. Leverson

AbbVie (United States)

ORCID: 0000-0003-1162-724X
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.

83 citations

Hui Yang, Feiyang Ma, Guillermo Montalban‐Bravo, Natthakan Thongon, Valentina Marchica +33 more

189 citations

Bridget Riley‐Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang +36 more

N/A
0.772DataRank · unranked
171 citations

Claudio A.P. Joazeiro, Andrew M. Page, Han-kuei Huang, Philip Hieter, Tony Hunter +1 more

24 citations

Katrina M. Hawley, David B. Banks, Anika Thomas-Toth, Bruce R. Blazar, Megan E. McNerney +3 more